ZA883133B - A stable lyophilized live herpes virus vaccine - Google Patents

A stable lyophilized live herpes virus vaccine

Info

Publication number
ZA883133B
ZA883133B ZA883133A ZA883133A ZA883133B ZA 883133 B ZA883133 B ZA 883133B ZA 883133 A ZA883133 A ZA 883133A ZA 883133 A ZA883133 A ZA 883133A ZA 883133 B ZA883133 B ZA 883133B
Authority
ZA
South Africa
Prior art keywords
herpes virus
virus vaccine
stable lyophilized
lyophilized live
live herpes
Prior art date
Application number
ZA883133A
Other languages
English (en)
Inventor
J. Mcaleer William
Z. Markus Henry
Z. Maigetter Robert
Original Assignee
Merck & Co.,Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co.,Inc. filed Critical Merck & Co.,Inc.
Publication of ZA883133B publication Critical patent/ZA883133B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0015—Combination vaccines based on measles-mumps-rubella
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA883133A 1987-05-04 1988-05-03 A stable lyophilized live herpes virus vaccine ZA883133B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4594087A 1987-05-04 1987-05-04

Publications (1)

Publication Number Publication Date
ZA883133B true ZA883133B (en) 1988-11-08

Family

ID=21940663

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA883133A ZA883133B (en) 1987-05-04 1988-05-03 A stable lyophilized live herpes virus vaccine

Country Status (16)

Country Link
EP (1) EP0290197B1 (sv)
JP (1) JP2643982B2 (sv)
KR (1) KR960016581B1 (sv)
AT (1) ATE95427T1 (sv)
AU (1) AU622110B2 (sv)
CA (1) CA1324956C (sv)
DE (1) DE3884663T2 (sv)
DK (1) DK238688A (sv)
FI (1) FI94093C (sv)
HK (1) HK5997A (sv)
IE (1) IE61575B1 (sv)
IL (1) IL86180A (sv)
NO (1) NO176163C (sv)
NZ (1) NZ224419A (sv)
PT (1) PT87388B (sv)
ZA (1) ZA883133B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2000034A6 (es) * 1985-11-26 1987-10-01 Schweiz Serum & Impfinst Procedimiento para la preparacion de una vacuna viva contra paperas
IL120202A (en) 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
GB9808922D0 (en) 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
HUP0202537A3 (en) 1999-08-24 2004-05-28 Teva Pharma A vaccine composition and method of using the same
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US9132184B2 (en) 2006-11-07 2015-09-15 Sanofi Pasteur Biologics, Llc Stabilization of vaccines by lyophilization
EP2699266B1 (en) * 2011-04-21 2019-06-12 Trustees Of Tufts College Compositions and methods for stabilization of active agents
EP3902529A1 (en) * 2018-12-27 2021-11-03 Amgen Inc. Lyophilized virus formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5341202B2 (sv) * 1974-03-12 1978-11-01
GB1481650A (en) * 1975-05-06 1977-08-03 Merck & Co Inc Chemical processes and products
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
US4859587A (en) * 1984-06-04 1989-08-22 Institut Merieux Recombinant herpes simplex viruses, vaccines and methods
ZA874625B (en) * 1986-06-30 1988-10-26 Smith Kline Rit Stabilizers for live vaccines,process for their preparation and vaccines containing them

Also Published As

Publication number Publication date
IE881248L (en) 1988-11-04
JP2643982B2 (ja) 1997-08-25
DK238688A (da) 1988-11-05
KR960016581B1 (ko) 1996-12-16
AU1552788A (en) 1988-11-10
NO176163B (no) 1994-11-07
IL86180A (en) 1992-08-18
HK5997A (en) 1997-01-17
NO176163C (no) 1995-02-15
PT87388A (pt) 1989-05-31
EP0290197A3 (en) 1989-10-18
NO881931L (no) 1988-11-07
NZ224419A (en) 1991-03-26
PT87388B (pt) 1992-08-31
DE3884663T2 (de) 1994-04-07
JPS646220A (en) 1989-01-10
AU622110B2 (en) 1992-04-02
DK238688D0 (da) 1988-05-03
ATE95427T1 (de) 1993-10-15
CA1324956C (en) 1993-12-07
DE3884663D1 (de) 1993-11-11
FI882041A0 (sv) 1988-05-02
NO881931D0 (no) 1988-05-03
FI882041A (sv) 1988-11-05
KR880013575A (ko) 1988-12-21
EP0290197A2 (en) 1988-11-09
EP0290197B1 (en) 1993-10-06
IL86180A0 (en) 1988-11-15
FI94093B (sv) 1995-04-13
FI94093C (sv) 1995-07-25
IE61575B1 (en) 1994-11-16

Similar Documents

Publication Publication Date Title
GB8704032D0 (en) Light emitter bias stabilization
DE3751811D1 (de) LH-RH-Analoga enthaltende Formulierungen
GB8815326D0 (en) Roots type blower
ZA889166B (en) 1,7-annelated indolecarboxylic acid esters and -amides
JPS6413097A (en) Phosphonic acid derivative
GB8826137D0 (en) Air extractor arrangements
HK5997A (en) Stable lyophilized live herpes virus vaccine
PL270529A1 (en) Weed killer
ZA887991B (en) Di-t-butylphenols substituted by an alkoxy or benzyloxy group or a benzylthio group
GB8720819D0 (en) Glyphosate formulations
GB8716074D0 (en) Blower
EP0284231A3 (en) Storage-stable polymerizable composition
MX9206973A (es) Vacuna a base de virus del herpes bovino modificado tipo 1.
GB8704647D0 (en) Vaccine
GB8702007D0 (en) Blower
AU102882S (en) A portble blower
GB9213882D0 (en) Live modified equine herpesvirus-4 vaccine
Kasilingam Tree parser
ZA883489B (en) Tree resistant compositions
CA56493S (en) Animal figurine (irish setter)
GB8728239D0 (en) Vacuum fly killer
PL266967A1 (en) Air grate
GB8710163D0 (en) Enhanced glyphosate formulations
GB8615114D0 (en) Live vaccine
PL279220A1 (en) Ash blower